FDA advisers recommend Pfizer RSV vax for 60+
The Food and Drug Administration (FDA) vaccine advisory group recommended approval of Pfizer’s respiratory syncytial virus (RSV) vaccine for use in people 60 and older, ahead of similar deliberations for GSK’s RSV vaccine in the same age-group. The recommendation came...
HIV vax aims to block virus before it takes root
The vaccine is designed to specifically enter basal, or base, cells in the mucosal epithelium. As those basal cells differentiate to build up the epithelial tissue, the vaccine is passed on to all newly made cells (represented in green). CREDIT: Marie-Claire Gauduin,...
Vaccine targets life-threatening fungal infections
A new vaccine from the University of Georgia could be the first clinically approved immunization to protect against invasive fungal infections, a growing concern as antifungal drug resistance increases. Fungal infections cause more than 1.5 million deaths worldwide...